ARCHIVES

Clearinghouse Delves Into Carcinogenesis Issues – Test Validity, Interpretation, In Vitro Methods

This article is from The Cancer Letter archive.

Vol. 03 No. 32 | August 12, 1977

Download PDF Visit The Full Archive

Related Articles

Public Interest Representatives Says Clearinghouse Delayed TRIS Action; Brown Refutes Charge

March 10, 1978

Bayer’s HER-2/neu Blood Test Cleared By FDA For Marketing.

December 15, 2000

Letrozole cuts risk of recurrent breast cancer in post-menopausal women.

October 17, 2003

NCI Bypass Budget Published, Seeks $2.7 Billion In FY98

June 14, 1996

NCAB Committee Seeks Organ Systems Upgrade

February 7, 1986

In Brief: appropriations Approved; Grants, contracts May Flow Unimpeded; NCI Positions An Issue

December 16, 1977